Lisdexamfetamine Dimesylate - NDC Database
0054-0370 Aug 25, 2023
Lisdexamfetamine Dimesylate 20 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
Lisdexamfetamine Dimesylate 20 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
0054-0371 Aug 25, 2023
Lisdexamfetamine Dimesylate 30 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
Lisdexamfetamine Dimesylate 30 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
0054-0372 Aug 25, 2023
Lisdexamfetamine Dimesylate 40 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
Lisdexamfetamine Dimesylate 40 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
0054-0373 Aug 25, 2023
Lisdexamfetamine Dimesylate 50 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
Lisdexamfetamine Dimesylate 50 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
0054-0374 Aug 25, 2023
Lisdexamfetamine Dimesylate 60 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
Lisdexamfetamine Dimesylate 60 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
0054-0375 Aug 25, 2023
Lisdexamfetamine Dimesylate 70 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
Lisdexamfetamine Dimesylate 70 mg Oral Capsule by Hikma Pharmaceuticals USA Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.